Trademark: 76178478
Word
ARDANA BIOSCIENCE
Status
Dead
Status Code
710
Status Date
Friday, May 3, 2013
Serial Number
76178478
Registration Number
3147061
Registration Date
Tuesday, September 26, 2006
Mark Type
1000
Filing Date
Monday, December 11, 2000
Published for Opposition
Tuesday, October 18, 2005
Cancellation Date
Friday, May 3, 2013

Trademark Owner History
ARDANA BIOSCIENCE LIMITED - Original Registrant
Coarsedata Limited - Original Applicant

Classifications
5 pharmaceutical preparations for medical diagnosis, namely, for the diagnosis of pregnancy; sanitary preparations, namely, tampons used for delivering pharmaceutical preparations to the female reproductive tract and tampons designed to reduce the chance of infection of the female reproductive tract; sanitary pads; sanitary napkins; dietetic products for medical use, namely, dietary supplements and food for medical restricted diets; diagnostic kits consisting primarily of medical diagnostic reagents and preparations for reproductive health uses, semen analysis, testing sperm fertilization capability, hormone level analysis for testing the presence and level of Luteneising Hormone (LH), Follicle Stimulating Hormone (FSH), Beta-Oestradiol, Prolactin, Progesterone, Human Chorionic Gonadotrophin (hCG) and Testosterone, to detect genital infections, to test for antibodies to various organisms, to detect markers of pre-term labor, pregnancy complications, miscarriage and implantation failure, to detect antiphospholipids, protein S deficiency, lupus anti-coagulant and factor V Leiden mutation, to detect markers of female fertility, to detect DAZL heterozygous mutation and associated biochemical markers such as testosterone for the analysis of DNA, RNA for the detection of disease or predisposition associated with reproduction, for the analysis of protein or other biochemical markers of disease or predisposition of disease, to detect biochemical markers which indicate disease or predisposition to disease; oral contraceptives; contraceptive foams
10 diagnostic kits consisting primarily of dipsticks, litmus paper, test-tubes, pipettes, stylets for drawing blood samples, plastic containers, slides, syringes, needles, spatulas and non-invasive devices, and medical diagnostic reagents and preparations for obtaining and testing biological samples for reproductive health uses, semen analysis, testing sperm fertilization capability, hormone level analysis for testing the presence and level of Luteneising Hormone (LH), Follicle Stimulating Hormone (FSH), Beta-Qestradiol, Prolactin, Progesterone, Human ChorionicGonadotrophin (hCG) and Testosterone, to detect genital infections, to test for antibodies to various organisms, to detect markers of pre-term labor, pregnancy complications, miscarriage and implantation failure, to detect antiphospholipids, protein S deficiency, lupus anti-coagulant and factor V Leiden mutation, to detect markers of female fertility, to detect DAZL heterozygous mutation and associated biochemical markers such as testosterone for the analysis of DNA, RNA for the detection of disease or predisposition associated with reproduction, for the analysis of protein or other biochemical markers of disease or predisposition of disease, to detect biochemical markers which indicate disease or predisposition to disease; surgical and medical apparatus, namely, dipsticks, litmus paper, test-tubes, pipettes, stylets for drawing blood samples, plastic containers, slides, syringes, needles, spatulas and non-invasive devices for obtaining and testing biological samples; diaphragms for contraception; coils for contraception; protective sheaths for contraception
35 medical assistance, namely the provision of medical support staff to clinics and medical practices for the screening of patients, auditing and maintenance of records, and consultation regarding diagnoses and treatment options; nursing services, namely providing nursing staff to doctors, clinics, hospitals and medical practices
42 Scientific research and development of new products for others; technical consultation and research in the fields of health, wellbeing, nursing, medicine and healthcare
44 Healthcare services; medical clinics; midwife services; provision of information relating to health, wellbeing, nursing, medicine and healthcare via the Internet
"BIOSCIENCE"
ARDANA BIOLOGY SCIENCE

Trademark Events
May 3, 2013
Cancelled Sec. 8 (6-Yr)
Sep 26, 2006
Registered-Principal Register
Jul 19, 2006
1(B) Basis Deleted; Proceed To Registration
Jul 7, 2006
Notice Of Allowance Cancelled
Jul 7, 2006
Teas Delete 1(B) Basis Received
May 24, 2006
Notice Of Allowance Correction Entered
May 2, 2006
Fax Received
Jan 10, 2006
Noa Mailed - Sou Required From Applicant
Oct 18, 2005
Published For Opposition
Sep 28, 2005
Notice Of Publication
Aug 19, 2005
Teas Change Of Correspondence Received
Jul 18, 2005
Law Office Publication Review Completed
Jun 9, 2005
Approved For Pub - Principal Register
Jun 9, 2005
Examiner's Amendment Entered
Jun 1, 2005
Assigned To Lie
May 31, 2005
Examiners Amendment E-Mailed
May 31, 2005
Examiners Amendment -Written
May 31, 2005
Previous Allowance Count Withdrawn
May 16, 2005
Withdrawn Before Publication
Feb 16, 2005
Law Office Publication Review Completed
Feb 14, 2005
Assigned To Lie
Jan 31, 2005
Assigned To Lie
Jan 25, 2005
Approved For Pub - Principal Register
Jan 25, 2005
Examiners Amendment E-Mailed
Jan 25, 2005
Examiners Amendment -Written
Jan 25, 2005
Previous Allowance Count Withdrawn
Dec 17, 2004
Law Office Publication Review Completed
Oct 4, 2004
Assigned To Lie
Sep 29, 2004
Approved For Pub - Principal Register
Sep 29, 2004
Amendment From Applicant Entered
Aug 24, 2004
Correspondence Received In Law Office
Aug 24, 2004
Teas Response To Office Action Received
Mar 8, 2004
Non-Final Action Mailed
Oct 24, 2003
Correspondence Received In Law Office
Nov 9, 2003
Case File In Ticrs
Oct 24, 2003
Teas Response To Office Action Received
Apr 25, 2003
Non-Final Action Mailed
Mar 21, 2003
Correspondence Received In Law Office
Mar 21, 2003
Paper Received
Sep 23, 2002
Inquiry As To Suspension Mailed
Jul 17, 2002
Teas Change Of Correspondence Received
Oct 15, 2001
Unresponsive/Duplicate Paper Received
Feb 5, 2002
Letter Of Suspension Mailed
Oct 11, 2001
Correspondence Received In Law Office
Apr 11, 2001
Non-Final Action Mailed
Apr 4, 2001
Assigned To Examiner

Trademark Alertz updated from USPTO on 2030-01-24